Tactile Systems Technology Inc(TCMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 5:57 PM ET (Korea 10/31 06:57)
Full metrics table
| Index | RUT | P/E | 21.22 | EPS (ttm) | 1.09 | Insider Own | 3.34% | Shs Outstand | 22.7M | Perf Week | -2.54% |
| Market Cap | 0.52B | Forward P/E | 15.03 | EPS next Y | 37.31% | Insider Trans | -2.02% | Shs Float | 21.9M | Perf Month | 6.13% |
| Enterprise Value | 0.47B | PEG | 0.4 | EPS next Q | 0.28 | Inst Own | 103.72% | Short Float | 12.93% | Perf Quarter | -22.63% |
| Income | 0.02B | P/S | 1.49 | EPS this Y | 36.18% | Inst Trans | -2.57% | Short Ratio | 9.93 | Perf Half Y | 0.66% |
| Sales | 0.35B | P/B | 2.34 | EPS next 5Y | 37.68% | ROA | 9% | Short Interest | 2.83M | Perf YTD | -20.55% |
| Book/sh | 9.86 | P/C | 7.47 | EPS past 3/5Y | - | ROE | 11.88% | 52W High | -39% ($37.77) | Perf Year | 52.89% |
| Cash/sh | 3.08 | P/FCF | 19.46 | Sales past 3/5Y | 10.12% 11.98% | ROIC | 10.58% | 52W Low | 55.26% ($14.84) | Perf 3Y | 111.57% |
| Dividend Est. | - | EV/EBITDA | 11.17 | EPS Y/Y TTM | 74.89% | Gross Margin | 76.08% | Volatility(W/M) | 3.03% 2.88% | Perf 5Y | -33.2% |
| Dividend TTM | - | EV/Sales | 1.33 | Sales Y/Y TTM | 17.22% | Oper. Margin | 10% | ATR (14) | 0.71 | Perf 10Y | 31.51% |
| Dividend Ex-Date | - | Quick Ratio | 3.68 | EPS Q/Q | 143.93% | Profit Margin | 7.1% | RSI (14) | 49.24 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.12 | Sales Q/Q | 8.61% | SMA20 | 0.35% ($22.96) | Beta | 0.96 | Target Price | $37.67 |
| Payout | - | Debt/Eq | 0.06 | Earnings | 2026/11/2 | SMA50 | 1.34% ($22.74) | Rel Volume | 0.74 | Prev Close | $24.31 |
| Employees | 1086 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | 151.85% 0.21% | SMA200 | -10.93% ($25.87) | Avg Volume(3M) | 0.28M | Price | $23.04 |
| IPO | 2016/7/28 | Option/Short | Yes/Yes | Trades | 3825 | Volume | 210,587 | Change | -5.22% |
🩺 Tactile Systems Technology (TCMD) is a U.S. medical device company that develops and sells home-use medical equipment for patients with chronic conditions. Its flagship products include pneumatic compression devices for lymphedema treatment (Flexitouch, Entre, and Nimbl) and airway clearance vests for respiratory illnesses (AffloVest), and the company is characterized by a high gross profit margin driven by its direct sales model.
Over the past 1 year, roughly in the middle
39% below its 1-year high.
Traded less than usual. That is 74% of its average volume.
Next earnings report: November 2
That is today.
TCMD makes money exceptionally well
Of every $100 in sales, $10.00 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +36.2% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,117. Peers typically go for $1,316. It is about in line with its own 3-year average.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -33.2%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership is about average
Institutions hold 103.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
HULL Corgi Shipping & Global Logistics ETF 0.01% 
XHE State Street SPDR S&P Health Care Equipment ETF 0.01% 
MYLD Cambria Micro and SmallCap Shareholder Yield ETF <0.01% 
VAMO Cambria ETF Trust Cambria Value and Momentum ETF <0.01% 
ROSC Hartford Multifactor Small Cap ETF <0.01% It ranks #54 of 142 in the industry
Based on market cap of $522M.
TCMD#54 Tactile Systems Technology Inc $522M PER 21.2 
SGHT#55 Sight Sciences Inc $513M PER - 
SENS#56 Senseonics Holdings Inc $503M PER - 
DCTH#57 Delcath Systems Inc $487M PER 2301.6 
SSII#58 SS Innovations International Inc $471M PER - 
FAQ
What kind of company is TCMD?
TCMD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of TCMD?
The market cap of TCMD is approximately $522M, ranking 3,094 within its sector.
What is the P/E ratio of TCMD?
TCMD has a P/E ratio of approximately 21.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for TCMD?
TCMD has recorded a 52-week high of $37.77 and a low of $14.84.
